1-6 of 6
Donna Forrest
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib

Clinical Trials & Observations Brief Report
Chan Y. Cheah, Kate Burbury, Jane F. Apperley, Francoise Huguet, Vincenzo Pitini, Martine Gardembas, David M. Ross, Donna Forrest, Philippe Genet, Philippe Rousselot, Nigel Patton, Graeme Smith, Cynthia E. Dunbar, Sawa Ito, Ricardo C. T. Aguiar, Olatoyosi Odenike, Alla Gimelfarb, Nicholas C. P. Cross, John F. Seymour
Journal: Blood
Blood (2014) 123 (23): 3574–3577.
https://doi.org/10.1182/blood-2014-02-555607
Published: 2014
Journal Articles

Outcome Of Patients With Double-Hit Lymphomas Treated With CODOX-M/IVAC + R Followed By Hematopoietic Stem Cell Transplantation In British Columbia

Haowei (Linda) Sun, MD, Kerry J. Savage, MD, MSc, Aly Karsan, MD, Graham W. Slack, MD, Cynthia L. Toze, MD, MHSc, FRCPC, Laurie H. Sehn, MD, MPH, Yasser R Abou Mourad, MD, FRCPC, Michael J. Barnett, BMBS, FRCPC, FRCP, FRCPath, Raewyn Broady, MBChB, FRACP, Joseph M. Connors, MD, Donna Forrest, MD, FRCPC, Randy D. Gascoyne, MD, Alina S. Gerrie, MD, Donna E. Hogge, MD, PhD, FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Thomas J. Nevill, MD, FRCPC, Stephen H. Nantel, MD, FRCPC, Maryse M. Power, MD, MRCPI, FRCPath, Heather J. Sutherland, MD, PhD, FRCPC, Diego Villa, MD, MPH, John D. Shepherd, MD, Kevin Song, MD
Journal: Blood
Blood (2013) 122 (21): 1788.
https://doi.org/10.1182/blood.V122.21.1788.1788
Published: 2013
Journal Articles

Achievement and Maintenance Of Deeper Molecular Response By Switching To Nilotinib In Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) With Residual Disease On Long-Term Imatinib: ENESTcmr 36-Month Follow-Up

Brian Leber, MD, Francisco Cervantes, MD, PhD, Nelson Spector, MD, PhD, Jeffrey H. Lipton, MD, PhD, Gabriel Etienne, MD, PHD, Ricardo Pasquini, MD, PhD, Nelma Christina Clementino, MD, Agnès Guerci-Bresler, MD, Donna Forrest, MD, FRCPC, Anthony P. Schwarer, MD, Sandip Acharya, LaTonya Collins, BSN, Tomasz Szczudlo, Timothy P. Hughes, MD, MBBS
Journal: Blood
Blood (2013) 122 (21): 94–95.
https://doi.org/10.1182/blood.V122.21.94.94
Published: 2013
Journal Articles

Combined Targeting of BCR-ABL and JAK2 with ABL and JAK2 Inhibitors Is Effective Against CML Patients' Leukemic Stem/Progenitor Cells.

Donna DeGeer, MSc, Paolo Gallipoli, MD, Min Chen, PhD, Ivan Sloma, PhD, Heather Jorgensen, PhD, Donna Forrest, MD, Karen Lambie, Helen Nakamoto, Kyi Min Saw, Matthew Chan, Kathleen Newmarch, Leon Zhou, Ali G. Turhan, MD, PhD, Ralph B. Arlinghaus, PhD, Allen C. Eaves, MD, FRCPC, PhD, Connie J. Eaves, PhD, Tessa L. Holyoake, PhD, FRCP, FRCPath, Xiaoyan Jiang, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3404.
https://doi.org/10.1182/blood.V116.21.3404.3404
Published: 2010
Journal Articles

Properties of CD34 + CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate

Xiaoyan Jiang, Donna Forrest, Franck Nicolini, Ali Turhan, Joelle Guilhot, Calvin Yip, Tessa Holyoake, Heather Jorgensen, Karen Lambie, Kyi Min Saw, Emily Pang, Ranko Vukovic, Paeta Lehn, Ashley Ringrose, Miao Yu, Ryan R. Brinkman, Clay Smith, Allen Eaves, Connie Eaves
Journal: Blood
Blood (2010) 116 (12): 2112–2121.
https://doi.org/10.1182/blood-2009-05-222471
Published: 2010
Includes: Supplemental data
Journal Articles

Properties of CD34 + CML Cells That Predict Clinical Response to Tyrosine Kinase Inhibitors.

Xiaoyan Jiang, MD, PhD, Donna Forrest, MD, Franck Nicolini, MD, PhD, Karen Lambie, Kyi Min Saw, Emily Pang, Ranko Vukovic, Clayton Smith, MD, Allen Eaves, MD, PhD, Connie Eaves, PhD
Journal: Blood
Blood (2007) 110 (11): 324.
https://doi.org/10.1182/blood.V110.11.324.324
Published: 2007